Myocardial Infarction
|
0.570 |
AlteredExpression
|
disease |
BEFREE |
We found that BRD4 protein expression was significantly increased in cardiomyocytes of MI rat model and cardiomyocytes under hypoxia, accompanied by the expression of natriuretic peptide A (NPPA) and natriuretic peptide B (NPPB).
|
29352508 |
2018 |
Myocardial Infarction
|
0.570 |
Biomarker
|
disease |
BEFREE |
An innovative natriuretic peptide analog named C<sub>N</sub>AA<sub>C</sub> (structurally consisting of the C-terminus and ring of ANP and the N-terminus of CNP) that has been shown to exhibit potent vasodilatory, diuretic, and hypotensive effects in our previous study was evaluated for the treatment of left ventricular dysfunction following myocardial infarction.
|
28855643 |
2017 |
Myocardial Infarction
|
0.570 |
GeneticVariation
|
disease |
BEFREE |
Subjects carrying the T2238C ANP gene variant have a higher risk to suffer a stroke or myocardial infarction.
|
26720342 |
2015 |
Myocardial Infarction
|
0.570 |
Biomarker
|
disease |
BEFREE |
The present study investigated the cardiac pathophysiology employing quantitative mRNA measurement of atrial and brain natriuretic peptides (ANP and BNP) in the myocardium as markers of cardiac strain, using autopsy materials consisting of acute ischemic heart disease (AIHD, n=40) with/without the pathology of apparent myocardial necrosis (n=19/21), recurrent myocardial infarction (RMI, n=19), chronic congestive heart disease (CHD, n=11) and right ventricular cardiomyopathy (RVC, n=5), as well as hemopericardium (HP, n=11) due to myocardial infarction (n=5) and aortic rupture (n=6), and acute pulmonary thromboembolism (PTE, n=5).
|
23131304 |
2012 |
Myocardial Infarction
|
0.570 |
Biomarker
|
disease |
BEFREE |
Atrial natriuretic peptide (ANP, also known as NPPA) and brain natriuretic peptide (BNP, also known as NPPB) have been determined as genetic factors for several diseases, including stroke and myocardial infarction, in human and rat models.
|
22400494 |
2012 |
Myocardial Infarction
|
0.570 |
Biomarker
|
disease |
LHGDN |
N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.
|
17292492 |
2007 |
Myocardial Infarction
|
0.570 |
Biomarker
|
disease |
RGD |
SERCA2a gene down-regulation in the non-infarcted myocardium of rats with MI does not correlate with ANP gene up-regulation, suggesting that the two genes are not antithetically regulated.
|
16087130 |
2005 |
Myocardial Infarction
|
0.570 |
GeneticVariation
|
disease |
BEFREE |
According to our knowledge, this study is the first to look for the potential association of the ScaI ANP gene polymorphism with the history of nonfatal myocardial infarction and the extent of coronary artery disease (CAD).
|
12514664 |
2003 |
Myocardial Infarction
|
0.570 |
GeneticVariation
|
disease |
LHGDN |
According to our knowledge, this study is the first to look for the potential association of the ScaI ANP gene polymorphism with the history of nonfatal myocardial infarction and the extent of coronary artery disease (CAD).
|
12514664 |
2003 |
Myocardial Infarction
|
0.570 |
Therapeutic
|
disease |
CTD_human |
Long-term effects of carvedilol on left ventricular function, remodeling, and expression of cardiac cytokines after large myocardial infarction in the rat.
|
11743230 |
2002 |
Myocardial Infarction
|
0.570 |
Biomarker
|
disease |
CTD_human |
Long-term effects of carvedilol on left ventricular function, remodeling, and expression of cardiac cytokines after large myocardial infarction in the rat.
|
11743230 |
2002 |
Myocardial Infarction
|
0.570 |
Biomarker
|
disease |
CTD_human |
Comparison of atrial natriuretic peptide versus nitroglycerin for reducing blood pressure in acute myocardial infarction.
|
9527094 |
1998 |
Myocardial Infarction
|
0.570 |
Therapeutic
|
disease |
CTD_human |
Comparison of atrial natriuretic peptide versus nitroglycerin for reducing blood pressure in acute myocardial infarction.
|
9527094 |
1998 |